Fisher M - Search Results

1

The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking.

Alam MR, Ming X, Dixit V, Fisher M, Chen X, Juliano RL. Alam MR, et al. Among authors: fisher m. Oligonucleotides. 2010 Apr;20(2):103-9. doi: 10.1089/oli.2009.0211. Oligonucleotides. 2010. PMID: 20038250 Free PMC article.

2

Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis.

Alam MR, Dixit V, Kang H, Li ZB, Chen X, Trejo J, Fisher M, Juliano RL. Alam MR, et al. Among authors: fisher m. Nucleic Acids Res. 2008 May;36(8):2764-76. doi: 10.1093/nar/gkn115. Epub 2008 Mar 26. Nucleic Acids Res. 2008. PMID: 18367474 Free PMC article.

3

Cellular delivery and biological activity of antisense oligonucleotides conjugated to a targeted protein carrier.

Kang H, Alam MR, Dixit V, Fisher M, Juliano RL. Kang H, et al. Among authors: fisher m. Bioconjug Chem. 2008 Nov 19;19(11):2182-8. doi: 10.1021/bc800270w. Bioconjug Chem. 2008. PMID: 18826264 Free PMC article.

4

Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor.

Ming X, Alam MR, Fisher M, Yan Y, Chen X, Juliano RL. Ming X, et al. Among authors: fisher m. Nucleic Acids Res. 2010 Oct;38(19):6567-76. doi: 10.1093/nar/gkq534. Epub 2010 Jun 15. Nucleic Acids Res. 2010. PMID: 20551131 Free PMC article.

5

The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides.

Ming X, Carver K, Fisher M, Noel R, Cintrat JC, Gillet D, Barbier J, Cao C, Bauman J, Juliano RL. Ming X, et al. Among authors: fisher m. Nucleic Acids Res. 2013 Apr 1;41(6):3673-87. doi: 10.1093/nar/gkt066. Epub 2013 Feb 8. Nucleic Acids Res. 2013. PMID: 23396438 Free PMC article.

6

Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.

Astriab-Fisher A, Sergueev D, Fisher M, Shaw BR, Juliano RL. Astriab-Fisher A, et al. Among authors: fisher m. Pharm Res. 2002 Jun;19(6):744-54. doi: 10.1023/a:1016136328329. Pharm Res. 2002. PMID: 12134943

7

Strategies for inhibition of MDR1 gene expression.

Xu D, Kang H, Fisher M, Juliano RL. Xu D, et al. Among authors: fisher m. Mol Pharmacol. 2004 Aug;66(2):268-75. doi: 10.1124/mol.66.2.268. Mol Pharmacol. 2004. PMID: 15266017

8

Inhibition of MDR1 expression with altritol-modified siRNAs.

Fisher M, Abramov M, Van Aerschot A, Xu D, Juliano RL, Herdewijn P. Fisher M, et al. Nucleic Acids Res. 2007;35(4):1064-74. doi: 10.1093/nar/gkl1126. Epub 2007 Jan 30. Nucleic Acids Res. 2007. PMID: 17264131 Free PMC article.

9

Targeted albumin-based nanoparticles for delivery of amphipathic drugs.

Xu R, Fisher M, Juliano RL. Xu R, et al. Among authors: fisher m. Bioconjug Chem. 2011 May 18;22(5):870-8. doi: 10.1021/bc1002295. Epub 2011 Apr 19. Bioconjug Chem. 2011. PMID: 21452893 Free PMC article.

10

Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA.

Alam MR, Ming X, Fisher M, Lackey JG, Rajeev KG, Manoharan M, Juliano RL. Alam MR, et al. Among authors: fisher m. Bioconjug Chem. 2011 Aug 17;22(8):1673-81. doi: 10.1021/bc200235q. Epub 2011 Jul 20. Bioconjug Chem. 2011. PMID: 21755983 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,588 results

Search Page

Filters